Company / Return on Assets (ROA)
Eledon Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-78.3%
FY2016
5-year range
-78.3% / -9.0%
FY2014-FY2016
Trend
-238.4%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -238% YoY in FY2016, a notable deviation from the 2-year average annual change of -198%.
Based on SEC 10-K filings.
-78.3% in FY2016.
Declined from -9.0% to -78.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, return on assets (roa) decreased 238.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2016 | -78.3% | -238.4% |
| FY2015 | -23.1% | -158.1% |
| FY2014 | -9.0% | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026